Berkshire’s $9.7 Billion OxyChem Deal Means What?
Buffett’s firm has spent years amassing a giant stake in Occidental Petroleum (NYSE: OXY), starting with a $10 billion preferred stock and warrant package in 2019 that helped Occidental fund its acquisition of Anadarko.
By mid-2025, Berkshire had built that into a 32.7% equity position, making OXY one of its six largest holdings.
» Read more about: Berkshire’s $9.7 Billion OxyChem Deal Means What? »
Read More
Paul Tudor Jones Just Dropped a Masterclass on How to Invest Now
Every fall, a tight-knit group of investors gathers for a friendly, but fiercely competitive, stock picking challenge. It’s hosted by Paul Tudor Jones, the legendary hedge fund manager. But it isn’t just for a good cause. The top picks from the event, backed by the likes of Bill Ackman and Stan Druckenmiller, would’ve returned 7x your money in just six months.
» Read more about: Paul Tudor Jones Just Dropped a Masterclass on How to Invest Now »
Read More
Is This Beaten-Down AI Powerhouse a Once-in-a-Decade Buying Opportunity?
Buying the dip can feel like a savvy move, but there’s a fine line between a bargain and a “falling knife.” The trick is knowing which is which.
When a company leads its industry, is riding powerful megatrends, and trades at a rare discount, buying the dip might not just be smart, it might be a steal.
» Read more about: Is This Beaten-Down AI Powerhouse a Once-in-a-Decade Buying Opportunity? »
Read More
Is Target Stock a Hidden Gem for Patient Value Investors?
Target (NYSE: TGT) hasn’t had the best run lately. In fact, shares have slid 29.9% so far this year, a sharp contrast to the broader market, with the S&P 500 flat on the year. It’s a tough pill to swallow, especially when you consider Target was already on the back foot coming into 2025.
But here’s the twist,
» Read more about: Is Target Stock a Hidden Gem for Patient Value Investors? »
Read More
1 Stock to Own for the Next Decade
Every once in a while, a company comes along that feels like the rare exception, a business so well-positioned, diversified, and forward-looking that it could anchor a portfolio for years.
Broadcom is one of those companies and it might be the single best position to hold for the foreseeable future.
Key Points
-
Broadcom combines cyclical chip sales with high-margin recurring software revenue from acquisitions like CA,
» Read more about: 1 Stock to Own for the Next Decade »
Read MoreThe Burst
AppLovin’s Rally Hits a Rough Patch
After an extraordinary run that sent shares soaring nearly 300% over the past year, AppLovin suddenly lost momentum in early October. The sell-off came as a shock to investors who had watched the ad-tech company become one of Wall Street’s brightest stars.
The trigger was a Bloomberg report revealing that the SEC had opened an investigation into AppLovin’s data-collection practices.
» Read more about: AppLovin’s Rally Hits a Rough Patch »
Read MoreThe Ivy
Can Unity’s Comeback Last?
Unity Software remains a cornerstone of modern game development, powering nearly half of all video games built today. After last year’s dull performance that strained investor patience and damaged developer trust, the company finally appears to be turning a corner.
Shares are up roughly 80% over the past year as Unity works through its turnaround plan and rebuilds credibility.
» Read more about: Can Unity’s Comeback Last? »
Read MoreThe Daily
Cathie Wood buys $56 million of megacap tech stock
Cathie Wood, head of Ark Investment Management, is best known for betting on early-stage tech names and high-growth innovators. But occasionally she makes a move into the megacap space when she sees value.
That’s what Wood did in the past week (Thanksgiving Week), adding about $56 million worth of a megacap tech name,
» Read more about: Cathie Wood buys $56 million of megacap tech stock »